These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17699758)

  • 1. Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma.
    Perrotta C; Bizzozero L; Falcone S; Rovere-Querini P; Prinetti A; Schuchman EH; Sonnino S; Manfredi AA; Clementi E
    Cancer Res; 2007 Aug; 67(16):7559-64. PubMed ID: 17699758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma.
    Perrotta C; Falcone S; Capobianco A; Camporeale A; Sciorati C; De Palma C; Pisconti A; Rovere-Querini P; Bellone M; Manfredi AA; Clementi E
    Cancer Res; 2004 Jun; 64(11):3767-71. PubMed ID: 15172982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
    Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
    Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytostatic murine B16 cell-pulsed dendritic cells induce effective protection against melanoma in mice.
    Joseph-Pietras D; Carlier A; Madoulet C; Albert P
    Anticancer Res; 2007; 27(6B):3865-74. PubMed ID: 18225544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3',5'-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells.
    Falcone S; Perrotta C; De Palma C; Pisconti A; Sciorati C; Capobianco A; Rovere-Querini P; Manfredi AA; Clementi E
    J Immunol; 2004 Oct; 173(7):4452-63. PubMed ID: 15383576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of interferon plus cyclosporine A following chemotherapy for disseminated melanoma.
    Charak BS; Sadowski RM; Mazumder A
    Cancer Res; 1992 Dec; 52(23):6482-6. PubMed ID: 1384963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
    Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
    Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
    Sarna S; Bhola RK
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
    Ko E; Luo W; Peng L; Wang X; Ferrone S
    Cancer Res; 2007 Aug; 67(16):7875-84. PubMed ID: 17699794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic GMP-dependent inhibition of acid sphingomyelinase by nitric oxide: an early step in protection against apoptosis.
    Barsacchi R; Perrotta C; Sestili P; Cantoni O; Moncada S; Clementi E
    Cell Death Differ; 2002 Nov; 9(11):1248-55. PubMed ID: 12404124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of hematologic and immunologic effects of high dose chemotherapy by interleukin-2 in a murine tumor model.
    Rinehart JJ; Triozzi PL; Lee MH; Aldrich W; Young D
    Mol Biother; 1992 Jun; 4(2):77-82. PubMed ID: 1515098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented antitumor effects of combination therapy with VEGF antibody and cisplatin on murine B16F10 melanoma cells.
    Ghosh S; Maity P
    Int Immunopharmacol; 2007 Dec; 7(13):1598-608. PubMed ID: 17996669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma.
    Schmitt E; Maingret L; Puig PE; Rerole AL; Ghiringhelli F; Hammann A; Solary E; Kroemer G; Garrido C
    Cancer Res; 2006 Apr; 66(8):4191-7. PubMed ID: 16618741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency.
    Yoshikawa T; Niwa T; Mizuguchi H; Okada N; Nakagawa S
    Gene Ther; 2008 Oct; 15(19):1321-9. PubMed ID: 18480845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy].
    Yao LC; Yang RJ
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2552-6. PubMed ID: 18067832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.
    Cho HI; Kim EK; Park SY; Lee SK; Hong YK; Kim TG
    Cancer Lett; 2007 Dec; 258(2):189-98. PubMed ID: 17931768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nitric oxide donor increases the effectiveness of cytostatic therapy and inhibits the development of drug resistance].
    Konovalova NP; Goncharova SA; Volkova LM; Raevskaia TA; Eremenko LT; Korolev AM
    Vopr Onkol; 2003; 49(1):71-5. PubMed ID: 12715374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCI-779 plus cisplatin is highly effective against human melanoma in a SCID mouse xenotranplantation model.
    Thallinger C; Poeppl W; Pratscher B; Mayerhofer M; Valent P; Tappeiner G; Joukhadar C
    Pharmacology; 2007; 79(4):207-13. PubMed ID: 17377418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
    Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.